1
William James Strong, Edward Paul Palmer: Speech coding hearing aid system utilizing formant frequency transformation. Brigham Young University, Criddle Thorpe & Western, September 27, 1977: US04051331 (69 worldwide citation)


A hearing aid system and method includes apparatus for receiving a spoken speech signal, apparatus coupled to the receiving apparatus for determining at successive intervals in the speech signal the frequency and amplitude of the largest formants, apparatus for determining at successive intervals th ...


2
Patrick W K Lee, James Strong, Matthew C Coffey: Reovirus for the treatment of cellular proliferative disorders. Oncolytics Biotech, Burns Doane Swecker & Mathis, October 24, 2000: US06136307 (48 worldwide citation)


Methods for treating proliferative disorders, by administering reovirus to a Ras-mediated proliferative disorder, are disclosed. The reovirus is administered so that it ultimately directly contacts ras-mediated proliferating cells. Proliferative disorders include but are not limited to neoplasms. Hu ...


3
Patrick W K Lee, James Strong, Matthew C Coffey: Reovirus for the treatment of neoplasia. Oncolytics Biotech, Burns Doane Swecker & Mathis, August 29, 2000: US06110461 (34 worldwide citation)


Methods for treating neoplasia, by administering reovirus to a Ras-mediated neoplasm, are disclosed. The reovirus is administered so that it ultimately directly contacts cells of the neoplasm. Human reovirus, non-human mammalian reovirus, and/or avian reovirus can be used. If the reovirus is human r ...


4
Patrick W K Lee, James Strong, Matthew C Coffey: Reovirus for the treatment of neoplasia. Oncolytics Biotech, Burns Doane Swecker & Mathis, July 17, 2001: US06261555 (16 worldwide citation)


Methods for treating neoplasia, by administering reovirus to a Ras-mediated neoplasm, and use of reovirus for manufacture of a medicament for the treatment of neoplasia, are disclosed. The reovirus is administered so that it ultimately directly contacts cells of the neoplasm. Human reovirus, non-hum ...


5
Patrick W K Lee, James Strong, Matthew C Coffey: Reovirus for the treatment of cellular proliferative disorders. Oncolytics Biotech, Burns Doane Swecker & Mathis, September 24, 2002: US06455038 (15 worldwide citation)


Methods for treating proliferative disorders, by administering reovirus to a Ras-mediated proliferative disorder, are disclosed. The reovirus is administered so that it ultimately directly contacts ras-mediated proliferating cells. Proliferative disorders include but are not limited to neoplasms. Hu ...


6
Patrick W K Lee, James Strong, Matthew C Coffey: Reovirus for the treatment of neoplasia. Oncolytics Biotech, Burns Doane Swecker & Mathis, February 5, 2002: US06344195 (15 worldwide citation)


Methods for treating neoplasia, by administering reovirus to a Ras-mediated neoplasm, are disclosed. The reovirus is administered so that it ultimately directly contacts cells of the neoplasm. Human reovirus, non-human mammalian reovirus, and/or avian reovirus can be used. If the reovirus is human r ...


7
Patrick W K Lee, James Strong, Matthew C Coffey: Reovirus for the treatment of cellular proliferative disorders. Oncolytics Biotech, Fish & Richardson P C, November 2, 2004: US06811775 (5 worldwide citation)


Methods for treating proliferative disorders, by administering reovirus to a Ras-mediated proliferative disorder, are disclosed. The reovirus is administered so that it ultimately directly contacts ras-mediated proliferating cells. Proliferative disorders include but are not limited to neoplasms. Hu ...


8
Patrick W K Lee, James Strong, Matthew C Coffey: Reovirus for the treatment of neoplasia. Oncolytics Biotech, Burns Doane Swecker & Mathis L, June 10, 2003: US06576234 (4 worldwide citation)


Methods for treating neoplasia, by administering reovirus to a Ras-mediated neoplasm, and use of reovirus for manufacture of a medicament for the treatment of neoplasia, are disclosed. The reovirus is administered so that it ultimately directly contacts cells of the neoplasm. Human reovirus, non-hum ...


9
James Strong, Richard A Tamburrino, John M Ryan, Roger W Leseberg, Ervin Goldfain, David M Babson, David Stephens, Angelo Martellaro: Wearable headlight devices and related methods. Integra Lifesciences Corporation, Jenkins Wilson Taylor & Hunt P A, December 2, 2014: US08899774 (3 worldwide citation)


Wearable headlight devices and related methods are provided and can include a luminaire that can include a housing having a luminaire vent therein for receiving cooling air and a light source contained within the housing. An air moving device can be located outside of the luminaire for facilitating ...


10
Patrick W K Lee, James Strong, Matthew C Coffey: Reovirus for the treatment of cellular proliferative disorders. Oncolytics Biotech, McKeon Meunier Carlin & Curfman, November 29, 2011: US08066985 (3 worldwide citation)


Methods for treating proliferative disorders, by administering reovirus to a Ras-mediated proliferative disorder, are disclosed. The reovirus is administered so that it ultimately directly contacts ras-mediated proliferating cells. Proliferative disorders include but are not limited to neoplasms. Hu ...



Click the thumbnails below to visualize the patent trend.